The FDA currently regulates AI in medical devices through existing pathways (510(k), De Novo, PMA). However, it has issued draft guidance and new discussion papers to address AI-specific risks, namely bias, transparency, and continuous learning. In this blog, we have...
You cannot copy content of this page
Contact Us!
Chat with Us on WhatsApp! We reply within 5 minutes!
